Molecular testing, such as the identification of the SS18-SSX2 fusion gene, has proven to be a valuable tool in confirming the diagnosis, distinguishing PPSS from other sarcomas and benign lesions with overlapping features [11]. Here, SSX2 is linked to sarcoma.